Study shows that Probi probiotics may delay the onset of gluten intolerance in children

74f53ea4-6a0a-4f3a-aac1-1ec8215749d2articleimage.jpg

11 Sep 2017 --- A clinical trial evaluating the effect of probiotics from Probi in children genetically predisposed for gluten intolerance has shown that these probiotics have a suppressing effect on celiac autoimmunity and may delay the onset of the disease. Celiac disease affects up to 3 percent of the population, and currently, the introduction of a lifelong gluten-free diet is the only available treatment.

The randomized, double-blind, placebo controlled intervention study was performed by Dr. Daniel Agardh and his research team at Lund University with the objective of evaluating the effect of Probi’s probiotic strains Lactobacillus plantarum Heal 9 and Lactobacillus paracasei 8700:2 on Celiac Disease (CD) autoimmunity. Seventy-eight asymptomatic children (3-7 years old) with an increased risk for developing CD were randomly allocated to a daily consumption of either the probiotic product or a placebo for a total period of 6 months while on a gluten-containing diet. The 78 children were identified as a subpopulation in a multinational and multiyear autoimmunity study with thousands of children.

The study results show that the levels of the disease-related antibodies were significantly reduced in the probiotic group and significantly increased in the placebo group during the course of the study. In addition, several significant differences were observed between the groups on a cellular level indicating that the probiotic may counteract CD-associated ongoing immunological and inflammatory response.

“To our knowledge, this is the first time a probiotic study has been performed on this specific population and the results show immune-supporting properties of these probiotics as well as a potential preventive effect on the development of CD,” says Daniel Agardh.

“This is an excellent example of a well-working collaboration between academia and the industry” says Peter Nählstedt, CEO of Probi AB. “We see a growing interest in children’s probiotics and these results enable Probi to build a product platform for children.”

“The probiotic was administered in a sachet, and the subjects were instructed to sprinkle the powder on their food or dissolve it in water. Probi has recently launched a new fast melting powder formulation which would be a suitable format for a commercial product,” Nählstedt tells NutritionInsight

“This was a study in a population that has, to our knowledge, not been studied before. We are very excited about the good results and based on the evaluation of the data we will now build our product platform for children. For companies that are interested in marketing a product with the strains, Probi is able to formulate a fast melting powder or other desired product format,” Nählstedt adds.

Probi’s proprietary probiotic strains Lactobacillus plantarum Heal 9 and Lactobacillus paracasei 8700:2 are patent protected, of human origin and are commercially available. The results of the study were presented at the International Celiac Disease Symposium in New Delhi, India, on 10 September.

By Lucy Gunn

Related Articles

Nutrition & Health News

Breakthrough study shows DuPont probiotics impact intestinal microbiota in colon cancer patients

22 Sep 2017 --- A research study conducted by the Sahlgrenska Academy at the University of Gothenburg in Gothenburg, Sweden, in collaboration with DuPont Nutrition & Health (DuPont), has produced breakthrough results demonstrating that probiotic intervention can positively alter and modify intestinal microbiota in patients with colon cancer.

Business News

ADM to explore personalized nutrition with Mayo Clinic

20 Sep 2017 --- Archer Daniels Midland Company (ADM) has announced a collaboration with Mayo Clinic in the field of personalized nutrition. The company will work with Mayo’s Microbiome Program, led by Dr. Heidi Nelson, to investigate microbial solutions to improve health and wellness, initially focusing on the maintenance of healthy body weight.

Nutrition & Health News

Sabinsa granted US patent for synbiotic composition of shelf-stable probiotic and cranberry fibers

18 Sep 2017 --- Sabinsa has been granted a US patent on the company’s shelf-stable probiotic LactoSpore in combination with cranberry seed fibers. The granted patent (US9717766) discloses a method of increasing the viable colony count of Bacillus coagulans MTCC 5856 in a synbiotic composition containing natural plant fibers from Vaccinium oxycoccos (cranberry). The cranberry fibers in this composition were observed to increase the viable count of Bacillus coagulans MTCC 5856.

Nutrition & Health News

Yogurt found to boost mineral density in bones

14 Sep 2017 --- Yogurt is known as a rich source of calcium, magnesium, B vitamins, protein, branched-chain amino acids, bioactive peptides and probiotics – and all of these might contribute to musculoskeletal health, a study recently published in the Osteoporosis International journal has noted. 

Nutrition & Health News

Omega 3: A rich source of health benefits and NPD opportunities

11 Sep 2017 --- Omega 3’s benefits keep making the news in the world of nutrition, with the fatty acids’ tight connection to the healthy aging trend just one of the reasons why omega 3 continues to be on the tips of everyone’s tongues.

More Articles
URL : http://www.nutritioninsight.com:80/news/study-shows-that-probi-probiotics-may-delay-the-onset-of-gluten-intolerance-in-children.html